Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinfiammatory drug indomethacin

Chemical Research in Toxicology

Volumn 16, Issue 1, 2003, Pages 28-37

  Dillon, Carolyn T ^a   Hambley, Trevor W ^a   Kennedy, Brendan J ^a   Lay, Peter A ^a   Zhou, Qingdi ^a   Davies, Neal M ^b   Biffin, J Ray ^c   Regtop, Hubert L ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Agricure Scientific Organics   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER COMPLEX; INDOMETACIN; SUPEROXIDE DISMUTASE; ZINC COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; GASTROINTESTINAL TOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; STOMACH ULCER; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CECUM; COPPER; EDEMA; ELECTRON SPIN RESONANCE SPECTROSCOPY; HEMOGLOBINS; HINDLIMB; INDOMETHACIN; MALE; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; ULCER; ZINC;

ANIMALIA;

EID: 0348037594     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx020078o     Document Type: Article

References (77)

1. Polisson, R. (1996) Nonsteroidal antiinflammatory drugs: practical and theoretical considerations in their selection. Am. J. Med. 100 (Suppl 2A), 31S-36S.
2. Hawkey, C. J. (1999) COX-2 inhibitors. Lancet 353, 307-314.
3. Hao, C.-M., Komhoff, M., Guan, Y., Redha, R., and Breyer, M. D. (1999) Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival. Am. J. Physiol. 277, F352-F359.
4. Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., Gumbs, C. P., Ebel, D. L., Quan, H., Larson, P. J., Schwartz, J. I., Musliner, T. A., Gertz, B. J., Brater, D. C., and Yao, S.-L. (2000) Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. Ann. Int. Med. 133, 1-9.
5. Laudanno, O. M., Cesolari, J. A., Esnarriaga, J., Rista, L., Piombo, G., Maglione, C., and Aramberry, L. J. (2000) Dano gastrointestinal inducido por celecoxib y rofecoxib, en ratas. Acta Gastroenterol. Latinoam. 30, 27-33.
6. Muscara, M. N., Vergnolle, N., Lovren, F., Triggle, C. R., Elliot., S. N., Asfaha, S., and Wallace, J. L. (2000) Selective cyclooxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br. J. Pharmacol. 129, 1423-1430.
7. Ghosh, P. (1999) The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin. Arthritis Rheum. 28, 211-267.
8. Black, W. C., Bayly, C., Belley, M., Chan, C.-C., Charleson, S., Denis, D., Gauthier, J. Y., Gordon, R., Guay, D., Kargman, S., Lau, C. K., Leblanc, Y., Mancini, J., Ouellet, M., Percival, D., Roy, P., Skorey, K., Tagari, P., Vickers, P., Wong, E., Xu, L., and Prasit, P. (1996) From indomethacin to a selective COX-2 inhibitor: development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. Biorg. Med. Chem. Lett. 6, 725-730.
9. Wallace, J. L., McKnight, W., Reuter, B. K., and Vergnolle, N. (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119, 706-714.
10. Kalgutkar, A. S., Marnett, A. B., Crews, B. C., Remmel, R. P., and Marnett, L. J. (2000) Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. J. Med. Chem. 43, 2860-2870.
11. Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., and Marnett, L. J. (2000) Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion ofnonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc. Natl Acad. Sci. U.S.A. 97, 925-930.
12. Sorenson, J. R. J. (1989) Copper complexes offer a physiological approach to treatment of chronic diseases. Prog. Med. Chem. 26, 437-568.
13. Sorenson, J. R. J. (1984) Copper complexes in biochemistry and pharmacology. Chem. Br. 1110-1113.
14. Blahova, M., Tumova, I., Sokolik, J., Gallasova, M., and Svec, P. (1994) Antiinflammatory activity of aqua(aryloxyacetato)copper-(II) complexes. Pharmazie 49, 373-374.
15. Lewis, A. J. (1978) A comparison of the antiinflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig. Agents Actions 3, 244-250.
16. Korolkiewicz, Z., Hac, E., Gagalo, I., Gorczyca, P., and Lodzinska, A. (1989) The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats. Agents Actions 26, 355-359.
17. Boyle, E., Freeman, P. C., Goudie, A. C., Mangan, F. R., and Thomson, M. (1976) The role of copper in preventing gastrointestinal damage by acidic antiinflammatory drugs. J. Pharm. Pharmacol. 28, 865-868.
18. Williams, D. A., Walz, D. T., and Foye, W. O. (1976) Synthesis and biological evaluation oftetrakis(acetylsalicylato)-μ-dicopper-(II). J. Pharm. Sci. 65, 126-128.
19. Mohan, G., and Nagar, R. (1992) Synthesis and antiinflammatory activity of N-pyridinobenzamide-2-carboxylic acid and its metal chelates. Indian J. Pharmacol. 24, 207-211.
20. Andrade, A., Namora, S. F., Woisky, R. G., Wiezel, G., Najjar, R., Sertie, J. A. A., and de Oliveira Silva, D. (2000) Synthesis and characterization of a diruthenium-ibuprofenato complex. Comparing its antiinflammatory activity with that of a copper-(II)-ibuprofenato complex. J. Inorg. Biochem. 81, 23-27.
21. Regtop, H. L., and Biffin, J. R. (1994) Preparation of divalent metal salt of indomethacin, U.S. Patent 5310936, Biochemical Veterinary Research Pty. Ltd., Australia.
22. Regtop, H. L., and Biffin, J. R. (1995) Divalent metal complexes of indomethacin, compositions and medical methods of use thereof, U.S. Patent 5466824, Biochemical Veterinary Research Pty. Ltd., Australia.
23. Weder, J. E., Hambley, T. W., Kennedy, B. J., Lay, P. A., MacLachlan, D., Bramley, R., Delfs, C. D., Murray, K. S., Moubaraki, B., Warwick, B., Biffin, J. R., and Regtop, H. L. (1999) Antiinflammatory dinuclear copper(II) complexes with indomethacin. Synthesis, magnetism and EPR spectroscopy. Crystal structure of the N,N-dimethylformamide adduct. Inorg. Chem. 38, 1736-1744.
24. Forsyth, S. F., Guilford, W. G., and Lawoko, C. R. O. (1996) Endoscopic evaluation of the gastroduodenal mucosa following non-steroidal antiinflammatory drug administration in the dog. N. Z. Vet. J. 44, 179-181.
25. Adams, S. S., and Cobb, R. (1967) Non-steroidal antiinflammatory drugs. Prog. Med. Chem. 5, 59-138.
26. Ruckebusch, Y., and Toutain, P. L. (1983) Nonsteroidal antiinflammatory agents: species differences in pharmacodynamics. Vet. Res. Commun. 7, 359-368.
27. Wright, M. R., Davies, N. M., and Jamali, F. (1997) Toxicokinetics of indomethacin-induced intestinal permeability in the rat. Pharmacol. Res. 35, 499-504.
28. Bertrand, V., Guessous, F., Le Roy, A.-L., Viossat, B., Fessi, H., El Abbouyi, A., Giroud, J.-P., and Roch-Arveiler, M. (1999) Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats. Effect on inducible NO synthase. Dig. Dis. Sci. 44, 991-999.
29. Abou-Mohamed, G., El-Kashef, H. A., Salem, H. A., and Elmazar, M. M. (1995) Effect of zinc on the antiinflammatory and ulcerogenic activities ofindometacin and diclofenac. Pharmacology 50, 266-272.
30. Singla, A. K., and Wadhwa, H. (1995) Zinc-indomethacin complex: synthesis, physicochemical and biological evaluation in the rat. Int. J. Pharm. 120, 145-155.
31. Sturniolo, G. C., Di Leo, V., Brollo, M., Fries; W., Mazzon, E., Ferronato, A., and D'Inca, R. (2000) The many functions of zinc in inflammatory conditions of the gastrointestinal tract. J. Trace Elem. Exp. Med. 13, 33-39.
32. Kaji, T., Fujiwara, Y., Sakurai, S., Yamamoto, C., Kozuka, H., and Koizumi, F. (1995) Zinc promotes the repair of wounded monolayers of cultured vascular endothelial cells. Res. Commun. Mol. Pathol. Pharmacol. 89, 189-198.
33. McCord, J. M. (1974) Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 185, 529-531.
34. Netter, P., Bannwarth, B., and Royer-Morrot, M.-J. (1989) Recent findings on the pharmacokinetics of non-steroidal antiinflammatory drugs in synovial fluid. Clin. Pharmacokin. 17, 145-162.
35. Auer, D. E., Ng, J. C., and Seawright, A. A. (1990) Effect of Palosein (superoxide dismutase) and catalase upon oxygen derived free radical induced degradation of equine synovial fluid. Equine Vet. J. 22, 13-17.
36. Czapski, G., and Goldstein, S. (1988) The uniqueness of superoxide dismutase (SOD) - Why cannot most copper compounds substitute SOD in vivo? Free Radical Res. Commun. 4, 225-229.
37. Nishiyama, J., Mizuno, M., Nasu, J., Kiso, T., Uesu, T., Maga, T., Okado, H., Tomoda, J., Yamada, G., and Tsuji, T. (1996) Immunoelectron microscopic localization of copper-zinc superoxide dismutase in human gastric mucosa. Acta Histochem. Cytochem. 29, 215-220.
38. Klinowski, E., Broide, E., Varsano, R., Eshchar, J., and Scapa, E. (1996) Superoxide dismutase activity in duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol. 8, 1151-1155.
39. Kohut, A., and Mojzis, J. (1993) Effect of allopurinol and superoxide dismutase on indomethacin-induced gastric lesions in the rat. Physiol. Res. 42, 273-276.
40. Janssen, A. M. L., Bosman, C. B., Kruidenier, L., Griffioen, G., Lamers, C. B. H. W., van Krieken, J. H. J. M., van de Velde, C. J. H., and Verspaget, H. W. (1999) Superoxide dismutases in the human colorectal cancer sequence. J. Cancer Res. Clin. Oncol. 125, 327-335.
41. Hardt, J., Larsson, L.-I., and Hougaard, D. M. (2000) Immunocytochemical evidence suggesting that diamine oxidase catalyses biosynthesis of γ-aminobutyric acid in antropyloric gastrin cells. J. Histochem. Cytochem. 48, 839-846.
42. Mozsik, G., Javor, T., Zsoldos, T., and Tigyi, A. (1984) The interrelationships between the development of ethanol-, HCl-, NaOH and NaCl-induced gastric mucosal damage and the gastric mucosal superoxide dismutase activity in the rats. Acta Phys. Hung. 64, 309-314.
43. 1 = ethanol, methanol). Inorg. Chem. 39, 3742-3748.
44. 2. FEBS Lett. 61, 209-212.
45. 2+ ion with milk xanthine oxidase. Biochim. Biophys. Acta 1544, 89-95.
46. Ciuffi, M., Cellai, C., Franchi-Micheli, S., Failli, P., Zilletti, L., Ginanneschi, M., Chelli, M., Papini, A. M., and Paoletti, F. (1998) An in vivo, ex vivo and in vitro comparative study of activity of copper oligopeptide complexes vs Cu(II) ions. Pharmacol. Res. 38, 279-287.
47. Melarange, R., Gentry, C., Blower, P. R., Toseland, C. D. N., and Spangler, R. (1995) Nabumetone, in contrast to etodolac, lacks gastrointestinal irritancy in the rat: assessment by the inflammatory marker, haptoglobin, and blood loss. Inflammopharmacology 3, 259-270.
48. Melarange, R., Blower, P. R., and Spangler, R. (1994) Comparison of the antiinflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration. Eur. J. Rheum. Inflam. 14, 23-27.
49. Dawson-Saunders: B.; Trapp, R. G. (1990) Basic and Clinical Biostatistics, Appleton and Lange, East Norwalk, CT.
50. Pagano, M., and Gauvreau, K. (1993) Principles of Biostatistics, Duxbury, Belmont, CA.
51. GraphPad Software, Inc. (1993) GraphPad Instat, San Diego, California.
52. Bruker WINEPR System (1990-1996) 2.11 ed., Bruker-Franzen Analytic GmbH.
53. Henke, S. L. (1999) Superoxide dismutase mimics as future therapeutics. Expert Opin. Ther. Pat. 9, 169-180.
54. Gutteridge, J. M. C. (1984) Tissue damage by oxy-radicals: the possible involvement of iron and copper complexes. Med. Biol. 62, 101-104.
55. Weser, U., Richter, C., Wendel, A., and Younes, M. (1978) Reactivity of antiinflammatory and superoxide dismutase active Cu(II)-salicylates. Bioinorg. Chem. 8, 201-213.
56. 2 and Cu, Co-erythrocuprein. Hoppe-Seylers Z. Physiol. Chem. 356, 739-745.
57. Sorenson, J. R. J. (1984) Bis(3,5-diisopropylsalicylato)copper(II), a potent radioprotectant with superoxide dismutase mimetic activity. J. Med. Chem. 27, 1747-1749.
58. Durackova, Z., and Labuda, J. (1995) Superoxide dismutase mimetic activity of macrocyclic Cu(II)-tetraanhydroaminobenzaldehyde (TAAB) complex. J. Inorg. Biochem. 58, 297-303.
59. McCord, J. M., and Fridovich, I. (1969) An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055.
60. Harrison, J. R., Rillema, D. P., Ham, J. H., IV, and Sando, J. J. (1986) Inhibition of phorbol ester stimulated interleukin 2 production by copper(II) complexes. Cancer Res. 46, 5571-5575.
61. Tabbi, G., Driessen, W. L., Reedijk, J., Bonomo, R. P., Veldman, N., and Spek, A. L. (1997) High superoxide dismutase activity of a novel, intramolecularly imidazolato-bridged asymmetric dicopper(II) species. Design, synthesis, structure, and magnetism of copper(II) complexes with a mixed pyrazole-imidazole donor set. Inorg. Chem. 36, 1168-1175.
62. 4, a lipophilic copper acetate derivative. Inorg. Chim. Acta 91, 237242.
63. 4 and the reaction with superoxide in aprotic systems. Biochim. Biophys. Acta 631, 232-245.
64. Abuhijleh, A. L. (1997) Ternary copper(II) complexes of the anticonvulsant drug valproate with diimines as superoxide dismutase mimics. J. Inorg. Biochem. 68, 167-175.
65. 3Cl] superoxide dismutase activity. J. Inorg. Biochem. 60, 219-230.
66. Younes, M., and Weser, U. (1977) Superoxide dismutase activity of copper-penicillamine: possible involvement of Cu(I) stabilized sulphur radical. Biochem. Biophys. Res. Commun. 78, 1247-1253.
67. Pierre, J.-L., Chautemps, P., Refaif, S., Beguin, C., El Marzouki, A., Serratrice, G., Saint-Aman, E., and Rey, P. (1995) Imidazolate-briged dicopper(II) and copper-zinc complexes of a macrocyclic ligand (cryptand). A possible model for the chemistry of Cu-Zn superoxide dismutase. J. Am. Chem. Soc. 117, 1965-1973.
68. Strothkamp, K. G., and Lippard, S. J. (1982) Chemistry of the imidazolate-bridged bimetallic center in the Cu-Zn superoxide dismutase and its model compounds. Acc. Chem. Res. 15, 318-326.
69. Kensler, T. W., and Trush, M. A. (1983) Inhibition of oxygen radical metabolism in phorbol ester-activated polynuclear leukocytes by an antitumor promoting copper complex with superoxide dismutase-mimetic activity. Biochem. Pharmacol. 32, 3485-3487.
70. 4 complexes in tissue distribution of the binary complex. Biochem. Pharmacol. 43, 1601-1612.
71. Sorenson, J. R. J. (1976) Copper chelates as possible active forms of the antiarthritic agents. J. Med. Chem. 19, 135-148.
72. Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H., and Davies, N. M. (2002) Copper complexes of non-steroidal antiinflammatory drugs: an opportunity yet to be realized. Coord. Chem. Rev. 232, 95-126.
73. Greenaway, F. T., Hahn, J. J., Xi, N., and Sorenson, J. R. J. (1998) Interaction ofCu(II) 3,5-diisopropylsalicylate with human serum albumin - an evaluation of spectroscopic data. Biometals 11, 21-26.
74. Greenaway, F. T., Riviere, E., Girerd, J. J., Labouze, X., Morgant, G., Viossat, B., Daran, J. C., Roch Arveiller, M., and Dung, N.-H. (1999) Copper(II) complexes of a nonsteroidal antiinflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-μ-(2-[3-(trifluoromethyl)phenyl] aminonicotinato)bis(dimethylsulfoxide) dicopper(II) complex at 190 K. Antiinflammatory properties. J. Inorg. Biochem. 76, 19-27.
75. Franco, L., and Velo, G. P. (1996) A copper-complex reduced gastric damage caused by acetylsalicylic acid and ethanol. Prostaglandins 51, 331-338.
76. El-Saadani, M. A., Nassar, A. Y., Abou El-Ela, S. H., Metwally, T. H., and Nafady, A. M. (1993) The protective effect of copper complexes against gastric mucosal ulcer in rats. Biochem. Pharmacol. 46, 1011-1018.
77. Naito, Y., Yoshikawa, T., Ando, T., Kishi, A., Ueda, S., Oyamada, H., and Kondo, M. (1992) Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients. J. Clin. Gastroenterol. 14, S131-S134.